Literature DB >> 9862717

Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development.

C A Cuff1, J Schwartz, C M Bergman, K S Russell, J R Bender, N H Ruddle.   

Abstract

Lymphotoxin (LT) plays an important role in inflammation and lymphoid organ development, though the mechanisms by which it promotes these processes are poorly understood. Toward this end, the biologic activities of a recently generated recombinant murine (m) LT alpha preparation were evaluated. This cytokine preparation was effective at inducing cytotoxicity of WEHI target cells with 50% maximal killing observed with 1.2 ng/ml. mLT alpha also induced the expression of inflammatory mediators in the murine endothelial cell line bEnd.3. rmLT alpha induced expression of the adhesion molecules VCAM, ICAM, E-selectin, and the mucosal addressin cellular adhesion molecule, MAdCAM-1. When mLT alpha, human (h) LT alpha, and mTNF-alpha were compared, mLT alpha was the most potent inducer of MAdCAM-1. None of these cytokines induced the peripheral node addressin, PNAd. mLT alpha also induced expression of the chemokines RANTES, IFN-inducible protein 10 (IP-10), and monocyte chemotactic protein 1 (MCP-1). mRNA levels peaked 4 h following treatment with mLT alpha and declined through the 24-h treatment period. LT alpha also induced chemokine protein within 8 h of treatment, which increased through the 24-h treatment period. These data demonstrate that the proinflammatory effects of LT alpha3 may be mediated in part through the induction of adhesion molecule and chemokine expression. Further, LT alpha3 may promote development of lymphoid tissue through induction of chemokines and the mucosal addressin MAdCAM-1. These data confirm previous observations in transgenic and knockout mice that LT alpha3 in the absence of LT beta carries out unique biologic activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862717

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Ectopic lymphoid organogenesis: a fast track for autoimmunity.

Authors:  C M Weyand; P J Kurtin; J J Goronzy
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

3.  A novel strategy for defining haplotypes by selective depletion using restriction enzymes.

Authors:  Anna S Smirnova; Kátia C Ferreira-Silva; Karina L Mine; Vinicius Andrade-Oliveira; Natalia Shulzhenko; Maria Gerbase-DeLima; Andrey Morgun
Journal:  Immunogenetics       Date:  2006-12-05       Impact factor: 2.846

Review 4.  EDA signaling and skin appendage development.

Authors:  Chang-Yi Cui; David Schlessinger
Journal:  Cell Cycle       Date:  2006-09-14       Impact factor: 4.534

5.  Lymphoid neogenesis and immune infiltration in aged liver.

Authors:  Pallavi Singh; Zeynep Z Coskun; Catriona Goode; Adam Dean; LuAnn Thompson-Snipes; Gretchen Darlington
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 6.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  A stimulation-dependent alternate core promoter links lymphotoxin α expression with TGF-β1 and fibroblast growth factor-7 signaling in primary human T cells.

Authors:  Brian H Yokley; Sandra T Selby; Phillip E Posch
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

Review 8.  Lymphotoxin and TNF: how it all began-a tribute to the travelers.

Authors:  Nancy H Ruddle
Journal:  Cytokine Growth Factor Rev       Date:  2014-02-12       Impact factor: 7.638

9.  Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.

Authors:  D R Roach; H Briscoe; B M Saunders; W J Britton
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

10.  Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Authors:  Luca Szalontay; Andrew V Schally; Petra Popovics; Irving Vidaurre; Awtar Krishan; Marta Zarandi; Ren-Zhi Cai; Anna Klukovits; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.